What do we do?

Our work allows cancer drugs to be efficiently produced, and delivered to cancerous tumors in a targeted fashion that doesn’t destroy the patient’s normal healthy cells indiscriminantly. We do this by simplifying and standardizing the production of antibody drug conjugates to treat cancer, using proprietary site-selective chemistries as protein modification technologies.

Our Work

Who are we?

We are established scientists and medical professionals determined to treat people around world with superior, targeted cancer therapeutics.

Our Company

Partnership opportunities

Leverage our novel chemistries to create your superior targeted therapeutics to treat cancer.

For partners

Investment opportunities

We have two parallel development paths: platform technology with the ability to be licensed by others and our own proprietary therapeutic products to treat cancer

For investors